127. 前頭側頭葉変性症 Frontotemporal lobar degeneration Clinical trials / Disease details

臨床試験数 : 90 / 薬物数 : 87 - (DrugBank : 30) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 88

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00545974 (ClinicalTrials.gov)	October 2007	16/10/2007	Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia	A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia	Frontal Lobe Dementia;Frontotemporal Lobe Dementia;Semantic Dementia	Drug: memantine;Drug: Placebo pill	University of California, San Francisco	Forest Laboratories	Completed	40 Years	80 Years	All	81	Phase 4	United States
2	NCT00594737 (ClinicalTrials.gov)	October 2007	7/1/2008	Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia	An Open Label Pilot Study of the Effects of Memantine Administration on FDG-PET in Frontotemporal Dementia	Frontotemporal Dementia	Drug: memantine hydrochloride	Tiffany Chow, MD	H. Lundbeck A/S	Completed	40 Years	80 Years	Both	17	Phase 3	Canada
3	NCT00200538 (ClinicalTrials.gov)	September 2005	12/9/2005	Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients	Double-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) Patients	Dementia	Drug: memantine	Nantes University Hospital	NULL	Completed	45 Years	75 Years	Both	52	Phase 2	France
4	NCT00187525 (ClinicalTrials.gov)	May 2004	13/9/2005	A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration		Frontotemporal Lobar Degeneration	Drug: Memantine	University of California, San Francisco	Forest Laboratories	Completed	40 Years	80 Years	Both		Phase 4	NULL